Core elements of national policy for digital health technology evidence and access
- PMID: 39138261
- PMCID: PMC11322556
- DOI: 10.1038/s41746-024-01209-2
Core elements of national policy for digital health technology evidence and access
Abstract
Digital health technologies (DHT) offer the ability to deliver personalized care, lower barriers to access, and positively impact health outcomes. However, DHT utilization is impacted by insufficient market access pathways. A policy “full-stack”—including regulatory authorization, product value assessment, pricing and reimbursement, and patient access infrastructure—offers a framework for DHT integration into national healthcare ecosystems. Consistent clinical evidence requirements across national jurisdictions will further increase DHT scalability.
Conflict of interest statement
The authors declare no competing interests.
References
-
- French National Authority for Health (HAS). Towards a European Evaluation Framework for Digital Medical Devices (DMDs) in the European Union—Launch of a European Taskforce. https://www.has-sante.fr/jcms/p_3382241/en/towards-a-european-evaluation... (2022).
-
- National Portal for eHealth Innovation (G_NIUS). Early Access to Reimbursement for Digital Devices (PECAN).https://gnius.esante.gouv.fr/en/financing/reimbursement-profiles/early-a... (2023).
-
- Federal Institute for Drugs and Medical Devices (BfArM). Digital Health Applications. https://www.bfarm.de/EN/Medical-devices/Tasks/DiGA-and-DiPA/Digital-Heal... (2019).
LinkOut - more resources
Full Text Sources
